• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自动化每日筛查心脏再同步治疗除颤器诊断对预测主要心血管事件的潜在价值:来自 Home-CARE(心脏再同步治疗中的家庭监测)研究的结果。

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.

机构信息

Cardiology Department, Universitätsklinikum Essen, Essen, Germany.

出版信息

Eur J Heart Fail. 2011 Sep;13(9):1019-27. doi: 10.1093/eurjhf/hfr089.

DOI:10.1093/eurjhf/hfr089
PMID:21852311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157971/
Abstract

AIM

To investigate whether diagnostic data from implanted cardiac resynchronization therapy defibrillators (CRT-Ds) retrieved automatically at 24 h intervals via a Home Monitoring function can enable dynamic prediction of cardiovascular hospitalization and death.

METHODS AND RESULTS

Three hundred and seventy-seven heart failure patients received CRT-Ds with Home Monitoring option. Data on all deaths and hospitalizations due to cardiovascular reasons and Home Monitoring data were collected prospectively during 1-year follow-up to develop a predictive algorithm with a predefined specificity of 99.5%. Seven parameters were included in the algorithm: mean heart rate over 24 h, heart rate at rest, patient activity, frequency of ventricular extrasystoles, atrial-atrial intervals (heart rate variability), right ventricular pacing impedance, and painless shock impedance. The algorithm was developed using a 25-day monitoring window ending 3 days before hospitalization or death. While the retrospective sensitivities of the individual parameters ranged from 23.6 to 50.0%, the combination of all parameters was 65.4% sensitive in detecting cardiovascular hospitalizations and deaths with 99.5% specificity (corresponding to 1.83 false-positive detections per patient-year of follow-up). The estimated relative risk of an event was 7.15-fold higher after a positive predictor finding than after a negative predictor finding.

CONCLUSION

We developed an automated algorithm for dynamic prediction of cardiovascular events in patients treated with CRT-D devices capable of daily transmission of their diagnostic data via Home Monitoring. This tool may increase patients' quality of life and reduce morbidity, mortality, and health economic burden, it now warrants prospective studies. ClinicalTrials.gov  NCT00376116.

摘要

目的

研究通过家庭监测功能以 24 小时间隔自动获取的植入式心脏再同步治疗除颤器(CRT-D)的诊断数据是否能够实现心血管住院和死亡的动态预测。

方法和结果

377 例心力衰竭患者接受了具有家庭监测功能的 CRT-D。在 1 年的随访期间,前瞻性地收集了所有因心血管原因导致的死亡和住院的数据以及家庭监测数据,以开发一种具有预设特异性为 99.5%的预测算法。该算法包括 7 个参数:24 小时平均心率、静息心率、患者活动、室性早搏频率、心房-心房间期(心率变异性)、右心室起搏阻抗和无痛性电击阻抗。该算法是使用 25 天的监测窗口开发的,该窗口在住院或死亡前 3 天结束。虽然个别参数的回顾性灵敏度范围为 23.6%至 50.0%,但所有参数的组合在检测心血管住院和死亡方面的灵敏度为 65.4%,特异性为 99.5%(相当于每位患者每年随访中出现 1.83 次假阳性检测)。与阴性预测因子发现相比,阳性预测因子发现后的事件相对风险估计值高 7.15 倍。

结论

我们开发了一种用于预测接受 CRT-D 治疗的患者心血管事件的自动化算法,该算法能够通过家庭监测功能每天传输其诊断数据。该工具可能会提高患者的生活质量,降低发病率、死亡率和医疗经济负担,现在需要前瞻性研究。ClinicalTrials.gov NCT00376116。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/046001bead47/hfr08903.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/a5370ab0e7c2/hfr08901.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/4f9f089ac032/hfr08902.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/046001bead47/hfr08903.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/a5370ab0e7c2/hfr08901.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/4f9f089ac032/hfr08902.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d5/3157971/046001bead47/hfr08903.jpg

相似文献

1
Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.自动化每日筛查心脏再同步治疗除颤器诊断对预测主要心血管事件的潜在价值:来自 Home-CARE(心脏再同步治疗中的家庭监测)研究的结果。
Eur J Heart Fail. 2011 Sep;13(9):1019-27. doi: 10.1093/eurjhf/hfr089.
2
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study.结合植入式除颤器的家庭监测时间趋势和基线患者风险特征预测心力衰竭住院:来自 SELENE HF 研究的结果。
Europace. 2022 Feb 2;24(2):234-244. doi: 10.1093/europace/euab170.
3
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.心脏再同步治疗联合除颤器对2型糖尿病心力衰竭患者进行多极起搏:对反应率和临床结局的影响
Cardiovasc Diabetol. 2017 Jun 9;16(1):75. doi: 10.1186/s12933-017-0554-2.
4
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击:前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
5
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.心脏再同步治疗可减少原发性而非继发性预防性植入式心律转复除颤器患者的室性心律失常:来自门诊心力衰竭试验中再同步治疗的见解。
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004875.
6
Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.在国家心血管数据注册植入式心脏复律除颤器登记处中,需要心室起搏的老年患者使用双腔或心脏再同步治疗除颤器的情况和结果。
JAMA Netw Open. 2021 Jan 4;4(1):e2035470. doi: 10.1001/jamanetworkopen.2020.35470.
7
Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.心脏再同步治疗患者的每日遥测护理:波兰的首次经验。
Kardiol Pol. 2016;74(8):741-748. doi: 10.5603/KP.a2016.0019. Epub 2016 Feb 22.
8
Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.心脏再同步治疗对心力衰竭门诊患者除颤复律试验中住院的影响。
Circulation. 2014 May 20;129(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000417. Epub 2014 Mar 7.
9
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study.多传感器算法预测植入设备患者的心力衰竭事件:MultiSENSE 研究结果。
JACC Heart Fail. 2017 Mar;5(3):216-225. doi: 10.1016/j.jchf.2016.12.011.
10
Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study.通过家庭监测预测心力衰竭患者的死亡率和再住院率——家庭护理试点研究
Clin Res Cardiol. 2006;95 Suppl 3:III29-35. doi: 10.1007/s00392-006-1306-6.

引用本文的文献

1
Automatic daily remote monitoring in heart failure patients implanted with a cardiac resynchronisation therapy-defibrillator: a single-centre observational pilot study.植入心脏再同步治疗除颤器的心力衰竭患者的每日自动远程监测:一项单中心观察性初步研究。
Arch Med Sci. 2021 Mar 25;19(1):73-85. doi: 10.5114/aoms/131958. eCollection 2023.
2
Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review.加速度计评估的身体行为及其与植入式心脏复律除颤器接受者临床结局的关联:一项系统综述。
Cardiovasc Digit Health J. 2021 Nov 24;3(1):46-55. doi: 10.1016/j.cvdhj.2021.11.006. eCollection 2022 Feb.
3

本文引用的文献

1
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.2010年欧洲心脏病学会(ESC)心力衰竭器械治疗指南重点更新:2008年ESC急慢性心力衰竭诊断和治疗指南以及2007年ESC心脏再同步化治疗指南的更新。由心力衰竭协会和欧洲心律协会特别贡献制定。
Eur J Heart Fail. 2010 Nov;12(11):1143-53. doi: 10.1093/eurjhf/hfq192.
2
Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.自动远程监测植入式心脏除颤器随访的疗效和安全性:Lumos-T 安全减少常规诊室设备随访(TRUST)试验。
Circulation. 2010 Jul 27;122(4):325-32. doi: 10.1161/CIRCULATIONAHA.110.937409. Epub 2010 Jul 12.
Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area.
在偏远农村地区,植入式除颤器的远程监测与不适当电击次数减少以及医疗评估时间缩短相关。
World J Cardiol. 2021 Mar 26;13(3):46-54. doi: 10.4330/wjc.v13.i3.46.
4
Transtelephonic ECG Monitoring to Guide Outpatient Antiarrhythmic Drug Therapy in Patients With Non-Permanent Atrial Fibrillation: Efficacy and Safety From a Single-Center Experience.经电话心电图监测指导非永久性心房颤动患者的门诊抗心律失常药物治疗:单中心经验的疗效与安全性
J Atr Fibrillation. 2019 Apr 30;11(6):2161. doi: 10.4022/jafib.2161. eCollection 2019 Apr.
5
Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure.植入式心脏装置诊断变量对预测轻度至中度心力衰竭患者死亡率的临床参数的增量价值。
J Am Heart Assoc. 2019 Jul 16;8(14):e010998. doi: 10.1161/JAHA.118.010998. Epub 2019 Jul 11.
6
[Basic structural features of a cardiac telemedicine center for patients with heart failure and implanted devices, cardiac arrhythmias, and increased risk of sudden cardiac death : Recommendations of the working group 33 Telemonitoring of the German Cardiac Society].[德国心脏病学会第33工作组远程监测:心力衰竭、植入式设备、心律失常及心脏性猝死风险增加患者的心脏远程医疗中心基本结构特征建议]
Herzschrittmacherther Elektrophysiol. 2019 Mar;30(1):136-142. doi: 10.1007/s00399-018-0606-7. Epub 2019 Jan 14.
7
Early Indication of Decompensated Heart Failure in Patients on Home-Telemonitoring: A Comparison of Prediction Algorithms Based on Daily Weight and Noninvasive Transthoracic Bio-impedance.家庭远程监测患者失代偿性心力衰竭的早期指征:基于日常体重和无创经胸生物阻抗的预测算法比较。
JMIR Med Inform. 2016 Feb 18;4(1):e3. doi: 10.2196/medinform.4842.
8
Comparison of partners-heart failure algorithm vs care alert in remote heart failure management.伴侣-心力衰竭算法与远程心力衰竭管理中的护理警报对比
World J Cardiol. 2015 Dec 26;7(12):922-30. doi: 10.4330/wjc.v7.i12.922.
9
[Implantable hemodynamic monitoring devices].
Herz. 2015 Nov;40(7):966-71. doi: 10.1007/s00059-015-4363-7.
10
Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure.出院当天的植入式设备诊断可识别出有心力衰竭早期再入院风险增加的心力衰竭患者。
Eur J Heart Fail. 2014 Apr;16(4):419-25. doi: 10.1002/ejhf.48.
3
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.心脏衰竭装置联合诊断可识别出后续有更高心力衰竭住院风险的患者:来自 PARTNERS HF(心力衰竭患者趋势信息获取、评估和症状相关性研究计划)研究的结果。
J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.
4
The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording.静息心率与接受动态 24 小时心电图记录的患者室性心律失常发生之间的关系。
Europace. 2010 Feb;12(2):261-5. doi: 10.1093/europace/eup344. Epub 2009 Nov 3.
5
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.欧洲心力衰竭患者心脏再同步治疗(心脏再同步治疗和植入式心脏复律除颤器)的实施:2004 年至 2008 年的变化。
Eur J Heart Fail. 2009 Dec;11(12):1143-51. doi: 10.1093/eurjhf/hfp149. Epub 2009 Nov 1.
6
Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT.对于接受心脏再同步治疗除颤器的患者,胸腔内阻抗和心室阻抗与心室容积变化相关。
Pacing Clin Electrophysiol. 2010 Jan;33(1):64-73. doi: 10.1111/j.1540-8159.2009.02579.x. Epub 2009 Oct 10.
7
The European cardiac resynchronization therapy survey.欧洲心脏再同步化治疗调查。
Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31.
8
Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.胸腔内阻抗的变化与急性失代偿性心力衰竭住院风险的后续变化相关:无需患者警报的植入式设备监测的临床实用性。
J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.
9
Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators.起搏器和植入式心脏复律除颤器的远程监测与随访
Europace. 2009 Jun;11(6):701-9. doi: 10.1093/europace/eup110.
10
Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.使用植入式除颤器监测胸内阻抗可减少心力衰竭患者的住院次数。
Pacing Clin Electrophysiol. 2009 Mar;32(3):363-70. doi: 10.1111/j.1540-8159.2008.02245.x.